Trials / Completed
CompletedNCT05819710
A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This is a study to investigate the next-day residual effects of a single bedtime dosing of 5 mg and 10 mg of TS-142 in Japanese healthy elderly participants in double-blind manner.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-142 | Single dose of 5 mg of TS-142 |
| DRUG | TS-142 | Single-dose of 10 mg of TS-142 |
| DRUG | Zopiclone | Single-dose of 7.5 mg of zopiclone |
| DRUG | Placebo | Single-dose of placebo |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2023-08-25
- Completion
- 2023-08-25
- First posted
- 2023-04-19
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05819710. Inclusion in this directory is not an endorsement.